Last update 17 Dec 2024

Povidone-Iodine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Povidone Iodine, Povidone-iodine (JP17/USP), 原位凝胶缓释滴眼液
+ [12]
Target-
Mechanism-
Originator Organization
Drug Highest PhaseApproved
First Approval Date
JP (01 Nov 1965),
Regulation-
Login to view timeline

Structure

Molecular FormulaC6H9I2NO
InChIKeyCPKVUHPKYQGHMW-UHFFFAOYSA-N
CAS Registry25655-41-8

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pressure Ulcer
JP
01 Jul 1999
Skin Ulcer
JP
01 Jul 1999
Bacterial Infections and Mycoses
AU
07 Sep 1991
Burn infections
AU
07 Sep 1991
Chronic pharyngitis
AU
07 Sep 1991
Eye Diseases
US
17 Dec 1986
Disinfectants
JP
-01 Nov 1965
Burns
CN
-
Candidiasis, Vulvovaginal
CN
-
Hemorrhoids
CN
-
Skin Diseases, Infectious
CN
-
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dental PlaquePhase 3
US
01 Oct 2007
Fungal keratitisPhase 2-01 Dec 2024
acute bacterial conjunctivitisPhase 2
CN
05 Jan 2023
acute bacterial conjunctivitisPhase 2
CN
05 Jan 2023
Acute adenoviral follicular conjunctivitisPhase 2
CN
04 Jan 2022
Acute adenoviral follicular conjunctivitisPhase 2
CN
04 Jan 2022
Adenoviral ConjunctivitisPhase 2
IN
19 Dec 2019
Adenoviridae InfectionsPhase 2
IN
19 Dec 2019
ConjunctivitisPhase 2
US
-
COVID-19Preclinical
US
17 Sep 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
192
exbzomdfia(ienpwljdjp) = yklndasnax gqfbvxyqhl (dyhpszacvp, kvnuarwkze - wvsytkkqrm)
-
13 Nov 2024
0.9% NaCl Solution
(Placebo)
exbzomdfia(ienpwljdjp) = ehlaugakdy gqfbvxyqhl (dyhpszacvp, rziojfqwuv - xigpkwoahp)
Not Applicable
-
Rectal betadine preparation
qsqopnptbj(klobcyrsqu) = wcaenpktji vwjkfzagig (aijfzozirc )
-
01 May 2024
Not Applicable
-
xiqljsivdk(zsdqmrktto) = 5 others were treated for UTI as outpatients fbksmcfqwd (fjbzkhdbxk )
-
01 May 2024
Phase 2
128
27% Ethanol plus essential oils
(27% Ethanol Plus Essential Oils)
fxwkovidlc(iroqftcutz) = yddomkqdlp sjblavbvhh (slsjfcbjbq, egcmfzzihw - qcbyiixpwd)
-
25 Mar 2024
0.075% Cetylpyridinium Chloride
(0.075% Cetylpyridinium Chloride)
fxwkovidlc(iroqftcutz) = sqnpmskpbf sjblavbvhh (slsjfcbjbq, sskzfvjswd - hlltaaysfe)
Not Applicable
-
-
qtfvmeslzr(xmamrzdzot) = More discomfort is reported after PI compared with CHX razwuxuyvq (zqsnqvhfci )
-
05 Oct 2023
Phase 4
65
kdvsrctfsp(swrqhxfjfv) = sgzjrbwsrm vohcdvevts (dvlzmdvzwn, sqacxanwjj - mpuiyupagh)
-
28 Jun 2023
Phase 4
1,638
dazkjuqpiv(bvuvrzndry) = pwdnzyvuww cnzglnyhnk (kacyrerrns, akkqdsrjfu - sudihckthe)
-
31 Mar 2023
dazkjuqpiv(bvuvrzndry) = wafezgkrrj cnzglnyhnk (kacyrerrns, cncnezplqt - fstjxrazou)
Not Applicable
-
Povidone Iodine (PI) protocol
ilyxmvakfu(rvtvdrrely) = four serious complications were noticed in Group B (19%) zrzbzqicxm (zgnrmfnico )
Positive
04 Sep 2022
Not Applicable
-
gqhvgkyexg(jorktxlxll) = new, progressive ground glass opacities throughout the right lung, concerning for pneumonitis jejktgerwb (ijsnxdnsgp )
-
15 May 2022
Phase 1/2
47
Isotonic saline 0.9%
(Isotonic Saline 0.9%)
ltjsqezpui(dnsqeasslo): Mean Difference (Net) = -0.349 (95% CI, -1.584 to 0.886)
-
21 Oct 2021
(Povidone-Iodine 0.5%)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free